Position in SHC
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,996,013
-$445,398 QoQ
Shares Held
139,192
+0.6% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SHC Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026HRT FINANCIAL LP holds $56,167,229 across 14 Diagnostics & Research names. SHC ranks #5 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
177,683 | $33,688,696 | |
| 2 | MYGN |
Myriad Genetics Inc
|
1,786,319 | $8,038,435 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
7,571 | $3,635,518 | |
| 4 | QGEN |
Qiagen N.V.
|
72,302 | $2,894,972 | |
| 5 | SHC |
Sotera Health Co
This page
|
139,192 | $1,996,013 | |
| 6 | ADPT |
Adaptive Biotechnologies Corp
|
131,241 | $1,821,625 | |
| 7 | PSNL |
Personalis, Inc.
|
208,891 | $1,330,635 | |
| 8 | VCYT |
Veracyte, Inc.
|
31,312 | $1,008,559 |
All Filings in SHC
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,996,013 | 139,192 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $2,441,411 | 138,402 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $3,406,252 | 216,545 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $548,905 | 49,362 | Shares | Defined | 2025-08-14 | |
| 2024-06-30 | $1,671,046 | 140,779 | Shares | Defined | 2024-08-12 | |
| 2023-12-31 | $747,398 | 44,356 | Shares | Defined | 2024-02-09 | |
| 2020-12-31 | $3,494,648 | 127,356 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||